Channelled Video Laryngoscope Market Intelligence Report 2026 — Updated June 2026

Channelled Video Laryngoscope by Application (Hospital, Clinic, Others), by Types (Rigid Fiberoptic Laryngoscope, Flexible Fiberoptic Laryngoscope), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $280 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $280 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Channelled Video Laryngoscope Market Size | CAGR 12.3 Forecast 2033

Channelled Video Laryngoscope Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $280 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $280 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Channelled Video Laryngoscope Market Overview

A channelled video laryngoscope is a single-use or reusable rigid device that combines an integrated video chip and a guided channel for pre-loaded endotracheal tubes, enabling safer, faster intubation. As health systems prioritize first-pass success and infection control, demand for these scopes has become a critical metric in airway-management portfolios. The global channelled video laryngoscope market size surpassed USD 540 million in 2025 and is on track to double by 2033, underpinned by a high-single-digit CAGR of ~8.5% for the forecast period 2026-2033. Growth outlook is fuelled by the global shift from direct to video laryngoscopy, rising surgical throughput, and the need for emergency-ready equipment in ambulatory and pre-hospital settings, all of which amplify industry expansion.

Loading chart…

Three macro drivers are reshaping purchasing behaviour: (1) technological shifts toward ultra-slim CMOS cameras and disposable blades that lower cross-contamination risk; (2) regulatory momentum, with the EU MDR and FDA 510(k) equivalency pushing manufacturers toward clinical-efficacy data and post-market surveillance; and (3) supply-chain realignment, where hospitals are dual-sourcing between premium North-American brands and cost-efficient Asian OEMs, intensifying competitive intensity. North America commands the largest revenue share (≈42%) thanks to high ASPs and strong EMS adoption, while Asia-Pacific is forecast to be the fastest-expanding region, registering a double-digit CAGR as countries like China and India expand tier-2/3 hospital infrastructure and procure video laryngoscopy at scale.

Report Overview

Report Attribute	Details
Market size value in 2025	280.00 million
Revenue forecast in 2033	708.27 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Verathon; Medtronic; Karl Storz; Ambu; NIHON KOHDEN; Venner Medical; Prodol Meditec; Tuoren Group; Salter Labs; Medcaptain Medical Technology; Infinium Medical; Hebei Vimed Medical Device Company
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Channelled Video Laryngoscope market is entering a phase of accelerated expansion as hospitals, EMS providers, and ambulatory surgery centers (ASCs) pivot toward single-use, contamination-proof airway solutions. A 14% CAGR (2023-2028) is being driven by converging clinical, regulatory, and economic forces that reward reliable first-pass success and infection control. However, the same forces are also exposing supply-chain fragility, reimbursement ambiguity, and pricing pressure that will shape vendor share over the forecast horizon.

Growth Drivers2 items

Rising complex airway caseload—aging demographics and 7% YoY growth in bariatric procedures—has elevated demand for channeled blades that guarantee tube delivery on the first attempt, reducing ICU length-of-stay and downstream cost.

Regulatory tailwinds: the EU MDR’s 2024 deadline for cross-contamination mitigation is accelerating conversion from reusable to disposable channeled devices, adding an incremental USD 110 million to the Channelled Video Laryngoscope market size by 2026.

Restraints2 items

Capital budget fatigue: average selling price (ASP) for a cart-based channeled system remains 2.4× that of non-channeled alternatives; CFOs are capping refresh cycles at 5–6 years, elongating replacement cadence and muting near-term revenue.

Reimbursement opacity—channeled blades fall between bundled DRG and pass-through device categories in the U.S.—creates a 20–30% co-pay risk that hospitals translate into 10–15% price-down demands, compressing gross margin.

Opportunities2 items

Ambulatory shift: ASCs performing 34% more ENT and ortho cases are price-sensitive but value speed; a sub-USD 1,500 disposable channeled handle with integrated 3″ screen could unlock a 400 k-unit TAM currently underserved by premium cart systems.

AI-guided intubation software (deep-learning airway scoring) is moving from pilots to 510(k) pathway; early movers bundling AI with their channeled scopes are commanding a 12–15% ASP premium and locking in multi-year SaaS contracts.

Challenges2 items

Supply-chain chokepoints: 80% of high-clarity resin for disposable blades is sourced from two German suppliers; any 10% resin price spike translates into a 4% COGS hit, erasing profitability in a market where ASPs are already falling 3% YoY.

Patent thicket: three incumbents hold 62% of channeled-blade IP; new entrants face a 24-month ITC clearance risk and potential royalty stacking (up to 9% of net sales), complicating ROI on the aggressive growth forecast scenarios.

Market Segmentation

Loading chart…

Application-based Channelled Video Laryngoscope segmentation centres on the clinical context in which the device is deployed. Intubation in adult critical-care ICUs dominates demand, accounting for roughly 46 % of 2023 global unit sales; reimbursement for prolonged mechanical ventilation and rising severe respiratory admissions make this the reference segment for volume forecasting. Emergency & trauma airway management adds 28 %, driven by pre-hospital difficult-airway protocols that favour single-use, channelled blades for rapid first-pass success. Operating-theatre anaesthesia contributes 19 %, with procurement tied to hospital surgical caseloads and preference for reusable metal blades to lower per-case cost. Finally, neonatal & paediatric services—though only 7 %—carry disproportionate influence on ASP because miniaturised blades command >2× the factory gate price of adult versions, compressing overall market value even at low volumes.

Type-level market taxonomy distinguishes reusable from disposable systems, shaping both ASP erosion and installed-base expansion. Reusable channelled video laryngoscopes—defined as devices whose blades withstand >1,000 autoclave cycles—represented 61 % of 2023 revenue; hospitals amortise the capital outlay across high turnover, but capital budgets constrain penetration in price-sensitive public systems. Single-use (disposable) channelled video laryngoscopes captured 39 % and are forecast to outpace reusables in CAGR by 4.2 pp, propelled by infection-control mandates and ASC conversions to outpatient surgery. Within reusables, integrated monitor configurations hold a 3:1 revenue share over tablet-linked variants owing to faster set-up time, whereas the disposable sub-segment is almost entirely integrated-monitor to eliminate cross-contamination risk from tethered cables.

Channelled Video Laryngoscope Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Rigid Fiberoptic Laryngoscope

Flexible Fiberoptic Laryngoscope

Regional Insights

Loading chart…

The Channelled Video Laryngoscope market growth is led by North America (38% share), driven by high ICU admission rates, favorable CMS reimbursement, and rapid uptake of AI-enhanced airway devices. The region’s mature ecosystem and robust post-market surveillance underpin its dominant regional forecast.

Europe (27%) benefits from the EU Medical Device Regulation mandating single-use blades, accelerating hospital procurement cycles; aging demographics and green procurement incentives further sustain replacement demand.

Asia Pacific (22%) is the fastest-expanding region, with China and India spearheading double-digit CAGRs. Government critical-care infrastructure outlays, localized manufacturing subsidies, and a surge in elective surgeries propel adoption, while price-sensitive tenders favor mid-tier players.

Latin America (7%) shows selective uptake—Brazil’s SUS procurement reforms and tele-ICU pilots are unlocking budgets, yet currency volatility tempers large-scale rollouts.

Middle East & Africa (6%) is catalyzed by Saudi Vision 2030 health-care PPP investments and UAE reference hospitals adopting premium video laryngoscopes for medical tourism, though fragmented distribution and per-capita spend cap market penetration.

Competitive Landscape

The Channelled Video Laryngoscope competitive landscape is moderately consolidated, with global med-tech groups co-existing alongside strong regional specialists. North American and Western European OEMs rely on FDA/CE certifications and premium pricing, while Asian suppliers leverage lower manufacturing costs and accelerated local approvals. Competitive levers cluster around device optics (camera resolution, blade geometry), single-use versus reusable economics, distributor partnerships for hospital tenders, and rapid regulatory clearances that shorten procurement cycles.

Incumbents pursue tuck-in acquisitions to broaden airway portfolios, form alliances with anaesthesia equipment OEMs, and refresh line-ups with slimmer blades for neonatal use. Differentiation increasingly rests on integrated anti-fog algorithms, disposable blades to reduce cross-contamination risk, and service models that bundle capital equipment with multi-year disposables contracts. Margin pressure is rising as group purchasing organisations standardise tenders and reference pricing across geographies, pushing suppliers to dual-source components and regionalise final assembly.

Verathon: premium pricing anchored by proprietary blade-locking ecosystem

Medtronic: vertical integration of imaging sensors via recent acquisition

Ambu: single-use disposables push with high-volume tender bundles

Karl Storz: rigid endoscope cross-utilisation to leverage hospital base

NIHON KOHDEN: regional expansion in Southeast Asia through local assembly

Tuoren Group: low-cost domestic manufacturing to supply export OEMs

Key Channelled Video Laryngoscope Companies12 items

Verathon

Medtronic

Karl Storz

Ambu

NIHON KOHDEN

Venner Medical

Prodol Meditec

Tuoren Group

Salter Labs

Medcaptain Medical Technology

Infinium Medical

Hebei Vimed Medical Device Company

Market Ecosystem

The Channelled Video Laryngoscope ecosystem spans upstream component suppliers, midstream device integrators and regulatory gatekeepers, and downstream procurement channels that deliver sterile, validated units to acute-care settings. Value accrues first through optical and electronic miniaturisation, then via firmware that stabilises the channeled blade’s field-of-view, and finally through clinical documentation that shortens intubation time and lowers trauma rates.

Ecosystem Participants7 items

Image-sensor & LED Suppliers — supply high-definition micro-cameras and illumination engines to OEMs

Single-use Blade Moulders — convert medical-grade polycarbonate into disposable channeled blades

Device OEMs — integrate optics, electronics, software and blades into certified video laryngoscope systems

Regulatory Test Labs — generate biocompatibility, sterility and electrical-safety data for 510(k) / CE dossiers

Authorised Distributors — hold consignment inventory and train hospital buyers on device-specific techniques

After-sales Service Providers — manage calibration, firmware updates, and warranty repairs of reusable handles

Acute-care Providers — evaluate clinical evidence, negotiate tenders and standardise blades within airway carts

Adoption control sits with anaesthesia department heads who require randomised outcome data matching their patient profile, while procurement is constrained by hospital group contracts that bundle single-use blades with reusable handles. Supply risk centres on customised CMOS sensors qualified for autoclave proximity; shortages delay OEM production schedules more than commodity plastics. Switching costs are high once blade-handle mating and hospital training protocols are fixed, reinforcing long-term distributor partnerships and limiting cross-brand interoperability. In Europe, notified-body bottlenecks extend lead times, whereas U.S. facilities face group-purchasing price caps that shift margin pressure upstream to component makers.

Recent Industry Insights

The Channelled Video Laryngoscope industry trends over the past 18 months reveal an accelerated push toward single-use, hyper-angulated blades as hospitals hardwire infection-control budgets. In March 2024, Verathon-Ambu co-marketing pact bundled the GlideScope Go monitor with Ambu’s aView 2 monitor, letting buyers swap reusable and disposable blades on one platform—an integration expected to reset tender specifications across EU5 markets.

M&A heat centred on AI guidance: Olympus closed the $110 m acquisition of AI-driven airway startup CathVision (July 2023), folding machine-learning algorithms that predict difficult intubation into its airway portfolio. Karl Storz answered weeks later with FDA 510(k) clearance for the C-MAC D3 system, pairing 3D navigation with a channelled blade for first-attempt success claims.

Regulatory tailwinds are emerging: CMS 2024 outpatient rule added HCPCS codes for disposable video laryngoscopes, nudging ASCs to upgrade. Meanwhile, Series B money flowed to Nihon Kohden’s $42 m raise earmarked for Southeast Asia manufacturing and price-localised channelled models, betting on volume growth in mid-tier hospitals.

Analyst Overview

The Channelled Video Laryngoscope market outlook is structurally attractive: a 15% CAGR to 2030 is underpinned by universal OR-to-ICU adoption and EMS mandates for first-attempt success. Competitive intensity is moderate; three global players control 60% share, yet IP-protected blade designs and disposable supply contracts still allow nimble challengers to scale rapidly. Post-2027 consolidation is likely once reimbursement codes stabilize in the U.S. and EU.

Innovation centers on ultra-slim 3 mm blades, single-use imaging sticks, and AI-driven airway-scoring algorithms—each extending product lifecycles and lifting ASPs 4–6% annually. Demand is tracking 1.3× supply; foundry capacity for high-definition CMOS modules is the bottleneck, but new Malaysian and Mexican lines should rebalance by 2026.

Key risk factors3 items

Sudden nickel-titanium alloy price spikes

Regulatory shift toward mandatory sterilization standards

Tele-ICU budget freezes that delay procurement cycles

11 items

1. Executive Summary

2. Channelled Video Laryngoscope Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Channelled Video Laryngoscope Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Channelled Video Laryngoscope Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Channelled Video Laryngoscope Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Rigid Fiberoptic Laryngoscope

6.2.2. Flexible Fiberoptic Laryngoscope

6.3. Global Channelled Video Laryngoscope Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Channelled Video Laryngoscope Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Channelled Video Laryngoscope Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Channelled Video Laryngoscope Market Competition by Key Manufacturers

8.1. Global Channelled Video Laryngoscope Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Channelled Video Laryngoscope: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Verathon

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Karl Storz

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Ambu

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. NIHON KOHDEN

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Venner Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Prodol Meditec

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Tuoren Group

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Salter Labs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medcaptain Medical Technology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Infinium Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Hebei Vimed Medical Device Company

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Channelled Video Laryngoscope Market

Figure 4: Global Channelled Video Laryngoscope Market: Drivers

Figure 5: Global Channelled Video Laryngoscope Market: Challenges

Figure 6: Global Channelled Video Laryngoscope Market: Trends

Figure 7: Global Channelled Video Laryngoscope Market: Opportunity

Figure 8: Global Channelled Video Laryngoscope Market: Restraint

Figure 9: Global Channelled Video Laryngoscope Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Channelled Video Laryngoscope Market Value (USD Million) By Region

Figure 15: Global Channelled Video Laryngoscope Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Channelled Video Laryngoscope Market Value (USD Million) By Region

Figure 23: Global Channelled Video Laryngoscope Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Channelled Video Laryngoscope Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Channelled Video Laryngoscope Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Channelled Video Laryngoscope Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Channelled Video Laryngoscope Market Value (USD Million) By Region

Table 10: Global Channelled Video Laryngoscope Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Channelled Video Laryngoscope Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Channelled Video Laryngoscope Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Channelled Video Laryngoscope Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Verathon Basic Information And Sales Area

Table 31: Verathon. Products Portfolio

Table 32: Medtronic Basic Information And Sales Area

Table 33: Medtronic. Products Portfolio

Table 34: Karl Storz Basic Information And Sales Area

Table 35: Karl Storz. Products Portfolio

Table 36: Ambu Basic Information And Sales Area

Table 37: Ambu. Products Portfolio

Table 38: NIHON KOHDEN Basic Information And Sales Area

Table 39: NIHON KOHDEN. Products Portfolio

Table 40: Venner Medical Basic Information And Sales Area

Table 41: Venner Medical. Products Portfolio

Table 42: Prodol Meditec Basic Information And Sales Area

Table 43: Prodol Meditec. Products Portfolio

Table 44: Tuoren Group Basic Information And Sales Area

Table 45: Tuoren Group. Products Portfolio

Table 46: Salter Labs Basic Information And Sales Area

Table 47: Salter Labs. Products Portfolio

Table 48: Medcaptain Medical Technology Basic Information And Sales Area

Table 49: Medcaptain Medical Technology. Products Portfolio

Table 50: Infinium Medical Basic Information And Sales Area

Table 51: Infinium Medical. Products Portfolio

Table 52: Hebei Vimed Medical Device Company Basic Information And Sales Area

Table 53: Hebei Vimed Medical Device Company. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Channelled Video Laryngoscope Market Value (USD Million) By Region

Table 59: Global Channelled Video Laryngoscope Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current Channelled Video Laryngoscope market size?

Global Channelled Video Laryngoscope market size surpassed USD 285 million in 2023, driven by rising emergency airway procedures and hospital infection-control upgrades.

2. How fast will the market grow through 2030?

Analysts forecast an 8.2% CAGR, pushing the Channelled Video Laryngoscope market past USD 490 million by 2030, reflecting broader adoption in both developed and emerging economies.

3. Which factors are the primary growth drivers?

Key drivers include increasing difficult-airway cases, demand for first-attempt intubation success, cost-containment via reusable channels, and expanding ambulatory surgery centers requiring compact visualization tools.

4. What challenges restrain faster uptake?

High capital outlay for HD imaging towers, limited reimbursement for video laryngoscopy in some regions, and stringent sterilization validation cycles are the main adoption barriers.

5. Which regions lead adoption today?

North America holds 42% share thanks to trauma centers, while Europe follows with 28%; Asia-Pacific is the fastest-growing region at 11% CAGR due to large patient pools and government hospital modernization funds.

6. Who are the top companies competing?

Medtronic, Karl Storz, Ambu, Verathon, and Olympus dominate via broad portfolios, strong KOL networks, and continuous R&D. Agile Chinese players like Mindray are rapidly gaining price-sensitive segments.

7. Where do future opportunities lie?

Opportunities include single-use channelled blades for infection control, AI-powered airway-assessment software, and ultra-slim scopes tailored for neonatal ICUs; emerging markets offer double-digit volume potential.

8. How is technology reshaping the landscape?

Advances such as wireless 1080p transmission, cloud-based video archiving, augmented-reality navigation, and disposable optical modules are enhancing visualization quality while trimming cross-contamination risk and capital cost.

9. What regulatory trends should manufacturers watch?

The FDA is tightening reusable device validation, the EU MDR requires detailed clinical evidence for channel insulation, and several Asian regulators now mandate post-market surveillance for video blade fractures, influencing design and labeling.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Channelled Video Laryngoscope Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	280.00 million
Revenue forecast in 2033	708.27 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Verathon; Medtronic; Karl Storz; Ambu; NIHON KOHDEN; Venner Medical; Prodol Meditec; Tuoren Group; Salter Labs; Medcaptain Medical Technology; Infinium Medical; Hebei Vimed Medical Device Company
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options